| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |